pirinixil has been researched along with thioacetamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Irsigler, K; Najemnik, C; Sirtori, CR | 1 |
| De Marchi, G; Lovati, MR | 1 |
| D'Atri, G; Galimberti, E; Gomarasca, P; Kritchevsky, D; Sirtori, CR | 1 |
1 trial(s) available for pirinixil and thioacetamide
| Article | Year |
|---|---|
Pilot study of pirinixil (BR 931) in various forms of hyperlipoproteinemias.
Topics: Aged; Cholesterol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Pyrimidines; Thioacetamide; Triglycerides | 1981 |
2 other study(ies) available for pirinixil and thioacetamide
| Article | Year |
|---|---|
Plasma lipoprotein composition in cholesterol fed rabbits treated with pirinixil (BR 931), a new lipid lowering agent.
Topics: Animals; Apolipoproteins; Cholesterol, Dietary; Depression, Chemical; Diet; Hypolipidemic Agents; Lipids; Lipoproteins; Lipoproteins, VLDL; Male; Pyrimidines; Rabbits; Thioacetamide | 1981 |
Clofibrate, pirinixil (BR 931) and WY-14,643 do not affect body cholesterol in Sprague-Dawley rats.
Topics: Animals; Anticholesteremic Agents; Aorta; Cholesterol; Cholesterol, Dietary; Clofibrate; Drug Evaluation, Preclinical; Intestinal Mucosa; Kidney; Liver; Lung; Male; Myocardium; Pyrimidines; Rats; Spleen; Thioacetamide | 1980 |